ClinicalTrials.gg
CompletedNCT03264508Updated Oct 28, 2021

Passive Heat Therapy and Age-associated Physiological Function

An interventional study of Heat therapy and Thermoneutral water immersion in Aging, sponsored by Douglas Seals. Completed at 1 site in United States. Open to participants aged 55 Years to 79 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-10-28.

Sponsored by Douglas Seals · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
55 Years to 79 Years
Sex
All
01

Study summary

This study aims to determine the effects of 8-10 weeks of repeated hot water immersion ("heat therapy") vs. thermoneutral water immersion on vascular function in late middle-aged to older (55-79 years) adults.

Read the detailed description

Advancing age is the primary risk factor for cardiovascular diseases (CVD), which remain the leading cause of death in the developed world. The key process that links aging to increased risk of CVD is the development of arterial dysfunction, including impaired endothelial function and arterial stiffening. In addition, age-associated impairments in arterial function have been linked to other diseases/disorders of aging, including cognitive impairments, Alzheimer's disease and dementia, and motor disorders/disability.

Passive heat therapy, in the form of repeated use of hot baths and saunas, has been used by several cultures for centuries; however, the physiological benefits are only now being elucidated. For example, recent studies have found that lifelong habitual sauna use is associated with considerably reduced risk of all-cause mortality, sudden cardiac death, CVD-related death, and Alzheimer's disease and dementia. In addition, 8-10 weeks of hot water immersion in young adults has been shown to improve endothelial function and reduces arterial stiffness and blood pressure. Therefore, the investigators expect heat therapy to similarly improve vascular function, as well as cognitive and motor function, in middle-aged to older adults who are at greater risk of CVD and related diseases/disorders.

02

Conditions studied

  • Aging

Keywords

  • endothelial function
  • arterial stiffness
  • heat
  • hot water immersion
03

In context

Lead sponsor

Douglas Seals is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
55 Years to 79 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ability to provide .
  • Aged 55-79 years. Women must be and not taking hormone replacement therapy within the past year.
  • Sedentary to recreationally active: participating in vigorous aerobic exercise \<4x/wk for ≥ 3 yrs.
  • Able to refrain from the use of dietary supplements, anti-inflammatory medications, and prescription medications for 24-48h prior to experimental testing.
  • Generally healthy (no overt clinical disease), as determined by medical history, physical examination, blood and urine chemistries.
  • Ankle-brachial blood pressure index >0.7
  • Total cholesterol \<240 mg/dl (\<6.2 mmol/L)
  • Fasting plasma glucose \<126 mg/dl (\<7.0 mmol/L)
  • Systolic blood pressure \< 160 mmHg and >100 mmHg
  • > 60 ml/min/1.73 m2
  • score > 20 points
  • (BMI) \<30 kg/m2
  • Weight stable in the prior 3 months (≤ 2 kg weight change) and willing to remain weight stable over the course of the study
  • Free from alcohol dependence or abuse, as defined by the American Psychiatry Association, (DSM-IV).

Exclusion criteria

Exclusion Criteria:

  • Current use of certain prescription medications that may interfere with thermoregulation and/or blood pressure control during heat stress. These include anti-hypertensives (in particular beta-blockers), nitrates and nitrites (e.g. nitroglycerin), PDE5 inhibitors (e.g. Viagra), anticholinergics (e.g. amitriptyline), and alpha-blockers (e.g. Flomax).
  • Orthostatic hypotension
  • Current or past smoking within the last 5 years
  • Recent major change in health status within previous 6 months (i.e. surgery, significant infection or illness).
  • Chronic clinical diseases (e.g., inflammatory bowel diseases/irritable bowel syndrome, coronary artery/peripheral artery/cerebrovascular diseases, diabetes, chronic kidney disease requiring dialysis, neurological disorders or diseases that may affect motor/cognitive functions [multiple sclerosis, Parkinson's disease, polio, Alzheimer's disease, dementia or other brain diseases of aging]).
  • History of heat-related illness
  • Open wounds or skin lesions. History of skin-related conditions or sensitivities to prolonged water immersion or exposure to pool chemicals.
  • Blood donation within the past 2 months
  • Inability to tolerate blood draws, intravenous catheters, and/or fingertip blood sampling, including past fainting in response to blood sampling.
  • Rectal, anal, vaginal, or prostate surgery within the last 6 months, current or recent (within the last 6 months) hemorrhoids, or related concerns regarding use of rectal thermistor
Terms in these criteria, in plain language(6)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

DSM diagnostic criteria

The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    Heat therapy

    Hot water immersion 3-4x per week for 8-10 weeks

    Behavioral: Heat therapy

  • Sham comparator
    Thermoneutral water immersion

    Thermoneutral water immersion 3-4x per week for 8-10 weeks

    Behavioral: Thermoneutral water immersion

Interventions

  • BehavioralHeat therapy

    30 sessions (3-4x per week for 8-10 weeks) of hot water immersion in 40°C water, sufficient to raise body core temperature to 38.5°C.

  • BehavioralThermoneutral water immersion

    30 sessions (3-4x per week for 8-10 weeks) of hot water immersion in 36°C water to prevent changes in body core temperature \>0.2°C.

06

What researchers measure

Primary outcomes

  1. Brachial artery flow-mediated dilation

    Measure of endothelial function

    Time frame: 0 and 8 weeks

  2. Carotid-femoral pulse wave velocity

    Measure of central arterial stiffness

    Time frame: 0 and 8 weeks

  3. Mean arterial blood pressure

    Brachial artery blood pressure, measured in triplicate (and averaged) following 20 min of supine rest

    Time frame: 0 and 8 weeks

Secondary outcomes

  1. Cerebrovascular reactivity

    Measure of cerebral vascular function; magnitude of increase in blood flow through the middle cerebral artery in response to breathing 5% CO2

    Time frame: 0 and 8 weeks

  2. Fluid cognition composite score

    Multiple domains of cognitive function (incl. executive function, memory, processing speed) assessed using the NIH toolbox (aggregated into one reported value)

    Time frame: 0 and 8 weeks

  3. Motor function composite score

    Multiple domains of motor function (incl. endurance, strength, dexterity) assessed using the NIH toolbox (aggregated into one reported value)

    Time frame: 0 and 8 weeks

07

Study locations

1 site
  • University of Colorado Boulder
    Boulder, Colorado 80309, United States
08

References and documents

Publications

  • Brunt VE, Howard MJ, Francisco MA, Ely BR, Minson CT. Passive heat therapy improves endothelial function, arterial stiffness and blood pressure in sedentary humans. J Physiol. 2016 Sep 15;594(18):5329-42. doi: 10.1113/JP272453. Epub 2016 Jun 30. PubMed 27270841 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Oct 2017 to primary completion in Nov 2020, 36 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 22, 2017
First posted
Aug 29, 2017
StartActual
Oct 25, 2017
Primary completionActual
Nov 23, 2020
CompletionActual
Jun 1, 2021
Last update
Oct 28, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 28, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03264508
Lead sponsor
Douglas Seals
Responsible party
Douglas Seals (Professor of Distinction, University of Colorado, Boulder) — Sponsor-investigator
First posted
Aug 29, 2017
Start date
Oct 25, 2017
Primary completion
Nov 23, 2020
Completion
Jun 1, 2021
Last update
Oct 28, 2021

Study contacts

Douglas R Seals, PhD
principal investigator · University of Colorado, Boulder

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion